Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41662225.
- Also identified by DOI 10.1371/journal.pmed.1004900 and PMC identifier 12885258.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Despite many antihypertensive options, uncontrolled hypertension remains pervasive. Aldosterone synthase inhibitors show robust blood pressure reductions and have the potential to reshape hypertension treatment, though cost and access may impact broad adoption.
Medical subject headings
- Hypertension
- Cytochrome P-450 CYP11B2
- Antihypertensive Agents
- Enzyme Inhibitors